[Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage* / Q000633:toxicity; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006168:Guinea Pigs; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009536:Niacinamide / Q000008:administration & dosage*; D011799:Quinazolines / Q000008:administration & dosage*; D011817:Rabbits; D051381:Rats
D000889:Anti-Arrhythmia Agents; D004338:Drug Combinations; D011799:Quinazolines; D009536:Niacinamide; C022128:changrolin